Your browser doesn't support javascript.
loading
Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling.
Pan, Liqiang; Fu, Tian-Min; Zhao, Wenbin; Zhao, Linlin; Chen, Wen; Qiu, Chixiao; Liu, Wenhui; Liu, Zhijun; Piai, Alessandro; Fu, Qingshan; Chen, Shuqing; Wu, Hao; Chou, James J.
Afiliação
  • Pan L; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA.
  • Fu TM; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
  • Zhao W; Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Province Key Laboratory of Anti-cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058 Hangzhou, China.
  • Zhao L; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA.
  • Chen W; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA.
  • Qiu C; Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Province Key Laboratory of Anti-cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058 Hangzhou, China.
  • Liu W; Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Province Key Laboratory of Anti-cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058 Hangzhou, China.
  • Liu Z; National Facility for Protein Science in Shanghai, ZhangJiang Lab, Chinese Academy of Sciences, 201210 Shanghai, China.
  • Piai A; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA.
  • Fu Q; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA.
  • Chen S; Institute of Drug Metabolism and Pharmaceutical Analysis and Zhejiang Province Key Laboratory of Anti-cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, 310058 Hangzhou, China. Electronic address: chenshuqing@zju.edu.cn.
  • Wu H; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA. Electronic address: wu@crystal.harvard.edu.
  • Chou JJ; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute at Harvard Medical School, 250 Longwood Avenue, Boston, MA 02115, USA. Electronic address: james_chou@hms.harvard.edu.
Cell ; 176(6): 1477-1489.e14, 2019 03 07.
Article em En | MEDLINE | ID: mdl-30827683

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores do Ligante Indutor de Apoptose Relacionado a TNF Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores do Ligante Indutor de Apoptose Relacionado a TNF Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos